Literature DB >> 8692964

Interleukin 7 receptor-deficient mice lack gammadelta T cells.

K Maki1, S Sunaga, Y Komagata, Y Kodaira, A Mabuchi, H Karasuyama, K Yokomuro, J I Miyazaki, K Ikuta.   

Abstract

The interleukin 7 receptor (IL-7R) plays a crucial role in early B- and T-cell development. It consists of a unique a chain and a common gamma chain [IL-2 receptor gamma chain (IL-2Rgamma)]. Gene inactivation of IL-7, IL-7R, and IL-2Rgamma resulted in severe impairment of B and T lymphopoiesis in mice. In addition, IL-2Rgamma-deficient mice lack gammadelta T cells in the skin and have the impaired development of natural killer (NK) cells and intraepithelial lymphocytes. To explore the role of IL-7/IL-7R system in gammadelta T- and NK-cell development, we have generated and analyzed IL-7R-deficient mice. gammadelta T cells were absent from skin, gut, liver, and spleen in the deficient mice. In contrast, alphabeta T and B cells were detected in reduced, but certain, numbers, and NK cells developed normally. The gammadelta T-cell development in fetal and adult thymus was also completely blocked. These results clearly demonstrate that the signal from IL-7R is indispensable for gammadelta T-cell development in both thymic and extrathymic pathways. On the contrary, it is suggested that NK-cell development requires cytokine(s) other than IL-7.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692964      PMCID: PMC38955          DOI: 10.1073/pnas.93.14.7172

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

Review 1.  Lymphocyte development from stem cells.

Authors:  K Ikuta; N Uchida; J Friedman; I L Weissman
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

2.  The liver as a potential hematolymphoid organ examined from modifications occurring in the systemic and intrahepatic hematolymphoid system during liver regeneration after partial hepatectomy.

Authors:  T Sakamoto; T Saizawa; A Mabuchi; Y Norose; T Shoji; K Yokomuro
Journal:  Reg Immunol       Date:  1992 Jan-Feb

3.  A developmental switch in thymic lymphocyte maturation potential occurs at the level of hematopoietic stem cells.

Authors:  K Ikuta; T Kina; I MacNeil; N Uchida; B Peault; Y H Chien; I L Weissman
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

Review 4.  The surrogate light chain in B-cell development.

Authors:  F Melchers; H Karasuyama; D Haasner; S Bauer; A Kudo; N Sakaguchi; B Jameson; A Rolink
Journal:  Immunol Today       Date:  1993-02

5.  Intrathymically expressed c-kit ligand (stem cell factor) is a major factor driving expansion of very immature thymocytes in vivo.

Authors:  H R Rodewald; K Kretzschmar; W Swat; S Takeda
Journal:  Immunity       Date:  1995-09       Impact factor: 31.745

6.  Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes.

Authors:  M Watanabe; Y Ueno; T Yajima; Y Iwao; M Tsuchiya; H Ishikawa; S Aiso; T Hibi; H Ishii
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

7.  A novel monoclonal antibody against murine IL-2 receptor beta-chain. Characterization of receptor expression in normal lymphoid cells and EL-4 cells.

Authors:  T Tanaka; M Tsudo; H Karasuyama; F Kitamura; T Kono; M Hatakeyama; T Taniguchi; M Miyasaka
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

8.  Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting.

Authors:  H Schorle; T Holtschke; T Hünig; A Schimpl; I Horak
Journal:  Nature       Date:  1991-08-15       Impact factor: 49.962

9.  Interleukin 7 preferentially supports the growth of gamma delta T cell receptor-bearing T cells from fetal thymocytes in vitro.

Authors:  Y Watanabe; T Sudo; N Minato; A Ohnishi; Y Katsura
Journal:  Int Immunol       Date:  1991-11       Impact factor: 4.823

10.  Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow.

Authors:  R R Hardy; C E Carmack; S A Shinton; J D Kemp; K Hayakawa
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more
  90 in total

Review 1.  Insights into T-cell development from studies using transgenic and knockout mice.

Authors:  M A Basson; R Zamoyska
Journal:  Mol Biotechnol       Date:  2001-05       Impact factor: 2.695

2.  Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency.

Authors:  C Miyaura; Y Onoe; M Inada; K Maki; K Ikuta; M Ito; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 3.  A survival guide to early T cell development.

Authors:  Maria Ciofani; Juan Carlos Zúñiga-Pflücker
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 4.  Clinical strategies to enhance T cell reconstitution.

Authors:  Gabrielle L Goldberg; Johannes L Zakrzewski; Miguel A Perales; Marcel R M van den Brink
Journal:  Semin Immunol       Date:  2007-10-26       Impact factor: 11.130

Review 5.  Differentiation, expansion, and homeostasis of autoreactive T cells in type 1 diabetes mellitus.

Authors:  Paolo Monti; Anne-Kristin Heninger; Ezio Bonifacio
Journal:  Curr Diab Rep       Date:  2009-04       Impact factor: 4.810

Review 6.  Type 1 diabetes therapy beyond T cell targeting: monocytes, B cells, and innate lymphocytes.

Authors:  F Susan Wong; Li Wen
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 7.  Clinical strategies to enhance thymic recovery after allogeneic hematopoietic stem cell transplantation.

Authors:  Enrico Velardi; Jarrod A Dudakov; Marcel R M van den Brink
Journal:  Immunol Lett       Date:  2013-10-08       Impact factor: 3.685

Review 8.  Intestinal intraepithelial T lymphocytes. Our T cell horizons are expanding.

Authors:  M Nanno; Y Kanamori; H Saito; M Kawaguchi-Miyashita; S Shimada; H Ishikawa
Journal:  Immunol Res       Date:  1998-08       Impact factor: 2.829

9.  Human intestinal epithelial cell-derived interleukin (IL)-18, along with IL-2, IL-7 and IL-15, is a potent synergistic factor for the proliferation of intraepithelial lymphocytes.

Authors:  A Okazawa; T Kanai; K Nakamaru; T Sato; N Inoue; H Ogata; Y Iwao; M Ikeda; T Kawamura; S Makita; K Uraushihara; R Okamoto; M Yamazaki; M Kurimoto; H Ishii; M Watanabe; T Hibi
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

10.  An overview of IL-7 biology and its use in immunotherapy.

Authors:  Nahed ElKassar; Ronald E Gress
Journal:  J Immunotoxicol       Date:  2010-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.